-

Kit Check Hosts Second Diversion Symposium to Elevate the National Conversation Around the Importance of Drug Diversion Prevention

The symposium brings together healthcare leaders across clinical disciplines to discuss how COVID-19 has affected drug diversion in the hospital space

WASHINGTON--(BUSINESS WIRE)--On April 27, 2021 from 12 p.m. to 3 p.m. ET, Kit Check, the industry leader in Medication Intelligence™ solution for hospitals, will host its second Diversion Symposium. This continuing education event for pharmacists, accredited for three credit hours by the Accreditation Council for Pharmacy Education (ACPE), will feature healthcare leaders across a diverse clinical background and their experience with preventing drug diversion in their institutions.

The symposium features presenters from the pharmacy and nursing departments of leading health systems including Jefferson Hospital of Allegheny Health Network, UCLA Santa Monica Medical Center and Sentara Norfolk General Hospital. Alise Elayne Hadley, Pharm.D., is the Director of Pharmaceutical Services at UCLA Santa Monica Medical Center and will explore the challenges and benefits of instituting a cross-department diversion prevention program with pharmacy and nursing. Sandee Seeley, RN, MSN, RN-BC, is a nurse manager at Jefferson Hospital and will walk attendees through the nursing perspective on diversion and benefits of a prominent nursing role in a controlled substance diversion program and committee. Cathy Richwine, RPh, BCSCP, is a Clinical Pharmacist and Catherine Floroff, PharmD, BCCCP, BCPS, is the Team Coordinator in Pharmacy at Sentara Norfolk General Hospital. They will explore lessons learned from using various diversion monitoring technology in efforts to minimize organizational risk.

“COVID-19 has sadly exacerbated the opioid epidemic, with overdose deaths increasing to all-time high levels,” said Kevin MacDonald, co-founder and CEO of Kit Check. “I am glad we are able to elevate the experience of industry leaders who have helped to curb drug diversion in their organizations and share that experience with a wider network of hospital clinicians. There are proven strategies and technologies to include in a best practice diversion prevention program, and we at Kit Check want to ensure this information is readily available to healthcare leaders”.

Register for the webinar here. Instructions will be provided for pharmacists to receive continuing education credits (up to three credit hours) from the Accreditation Council for Pharmacy Education (ACPE).

About Kit Check

Kit Check® is the leading provider of automated solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking Medication Intelligence™ solutions provide item-level visibility, workflow simplicity, and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 700 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems. Kit Check Solutions help providers save time managing inventory, prevent diversion at their facilities, save money on medication spend, and ensure patient safety. More information about Kit Check and our software solutions can be found at kitcheck.com.

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com
978-518-4528

Kit Check


Release Summary
Kit Check hosts second Diversion Symposium to elevate the national conversation around the importance of drug diversion prevention
Release Versions

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com
978-518-4528

More News From Kit Check

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

ALEXANDRIA, Va.--(BUSINESS WIRE)--BluesightⓇ, The Medication Intelligence™ Company, today published the results of a recent survey measuring U.S. consumers’ trust in the U.S. healthcare system and pharmaceutical industry, which revealed that trust in both is below average. The study also explored how prior knowledge about drug diversion – among other factors – may impact patient perception and decisions about where to seek care. “Through our suite of software solutions, Bluesight aims to provid...

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ

LAS VEGAS--(BUSINESS WIRE)--Kit Check today announced that it has rebranded as BluesightⓇ, The Medication Intelligence™ Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected. Founded in 2011, Bluesight provides unit-level visibility of pharmaceutical products from manufacturing plant to patient, addressing challenges suc...

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health sy...
Back to Newsroom